Nama's AI scorecard currently rates Waters Hold (4.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is WAT's P/E ratio?

Waters trades at a trailing price-to-earnings ratio of 31.8.

When does WAT report earnings?

Waters's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $4.66.

What is the WAT price target?

The median analyst price target from 22 analysts is $477.50, with a range of $349.00 – $550.00.

Is WAT Shariah compliant?

Nama's AAOIFI-style screen reads Waters as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Waters (WAT)

Healthcare · Diagnostics Research · NYSE

S&P 500

Waters (WAT) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $44.93B, a trailing price-to-earnings ratio of 31.8 and a free-cash-flow yield of 2.0%. Over the most recent reported fiscal year, revenue grew 7.0% and free cash flow per share fell 13.1%. Nama's AI scorecard rates it Hold, 4.5 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Hold · 4.5/10

The sections balance. As of Nov 7, 2026.

Momentum

Rising · +17.5% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-5.1%

How far the last close sits under the highest price of the past five years.

Market cap	$44.93B
Trailing P/E	31.8
Price / book	3.0
Price / sales	9.7
FCF yield	2.0%
Dividend yield	—
Gross margin	50.9%
Operating margin	8.2%
Net margin	3.6%
Revenue growth (YoY)	+7.0%
Revenue growth (3-yr annual)	+2.1%
EPS growth (YoY)	+10.6%
FCF/share growth (YoY)	-13.1%
Beta	1.1
Exchange	NYSE
Sector	Healthcare
Industry	Diagnostics Research

WAT earnings

Next report: Feb 10, 2027 (Q4 2026, EPS estimate $4.66). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 3, 2026	$4.10	$4.00	+2.5%	—
Q2 2026	Aug 4, 2026	$3.05	$3.01	+1.3%	$1.65B
Q1 2026	May 5, 2026	$2.70	$2.31	+16.9%	$1.27B
Q4 2025	Feb 9, 2026	$4.53	$4.51	+0.4%	$932.36M

WAT analyst price target

Median target $477.50 from 22 analysts, ranging $349.00 – $550.00.

Diagnostics Research peers

Ticker	Company	Market cap	P/E
TMO	Thermo Fisher Scientific	$257.42B	28.1
DHR	Danaher	$161.86B	27.6
IDXX	IDEXX Laboratories	$53.26B	45.6
A	Agilent Technologies	$49.28B	28.8
IQV	IQVIA	$44.80B	21.2
NTRA	Natera	$44.78B	—
MTD	Mettler-Toledo International	$34.51B	37.2
ILMN	Illumina	$32.23B	40.6

Explore live WAT data on Nama Insights →

Recent Congressional trades

Waters trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 1, 2026
Thomas H Tuberville	Senate	Sell	$1,001 - $15,000	Aug 5, 2026
Thomas H. Kean	House	Sell	$1,001 - $15,000	Apr 13, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 7, 2026
Thomas H. Kean	House	Sell	$1,001 - $15,000	Mar 18, 2026
Kevin Hern	House	Exchange	$1,001 - $15,000	Mar 6, 2026
Debbie Dingell	House	Exchange	$1,001 - $15,000	Feb 23, 2026
Julia Letlow	House	Buy	$1,001 - $15,000	Jan 13, 2026
Julia Letlow	House	Sell	$1,001 - $15,000	Jan 13, 2026
Julia Letlow	House	Buy	$1,001 - $15,000	Jan 13, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Oct 10, 2025
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Sep 12, 2025

WAT FAQ

Is WAT a buy?: Nama's AI scorecard currently rates Waters Hold (4.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is WAT's P/E ratio?: Waters trades at a trailing price-to-earnings ratio of 31.8.
When does WAT report earnings?: Waters's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $4.66.
What is the WAT price target?: The median analyst price target from 22 analysts is $477.50, with a range of $349.00 – $550.00.
Is WAT Shariah compliant?: Nama's AAOIFI-style screen reads Waters as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.